Poor Responses to Pneumococcal Vaccination in CKD Patients—Do We Need to Talk About Cytomegalovirus Again?
- 30 January 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (4), e890-e891
- https://doi.org/10.1093/cid/ciab084
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Subversion of Immune Response by Human CytomegalovirusFrontiers in Immunology, 2019
- HCMV-Encoded NK Modulators: Lessons From in vitro and in vivo Genetic VariationFrontiers in Immunology, 2018
- Incidence of invasive pneumococcal disease in immunocompromised patients: A systematic review and meta-analysisTravel Medicine and Infectious Disease, 2018
- “Natural Regulators”: NK Cells as Modulators of T Cell ImmunityFrontiers in Immunology, 2016
- Cytomegalovirus latency and reactivation: recent insights into an age old problemReviews in Medical Virology, 2015
- The pathogenesis of human cytomegalovirusThe Journal of Pathology, 2014
- Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory CommitteeClinical Infectious Diseases, 2004